Skip to content

Advance Care Planning in Cognitive Disorders Clinic

Responses to a Standardized Approach to Advance Care Planning in Cognitive Disorders Clinic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03864965
Enrollment
38
Registered
2019-03-06
Start date
2019-07-01
Completion date
2022-06-09
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning

Keywords

Alzheimer's disease, Dementia

Brief summary

Advance care planning among patients with cognitive disorders poses unique challenges to clinicians. To improve planning in patients with Alzheimer's disease and other dementias, the researchers suggest a routine, standardized approach to these conversations. The main outcome measure is the rate of entry of Advance Directive completion in the patient's Electronic Health Record (EHR). A control group of similar patients from another provider specializing in cognitive disorders will be used to tease out confounding variable effects.

Interventions

OTHERAdvance Care Planning

The provider will guide advance care planning conversations with patients identified with mild or moderate dementia during their third office visit, approximately three months after the first visit.

Sponsors

Florida Department of Health
CollaboratorOTHER_GOV
University of Florida
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients having mild cognitive impairment (MCI) or very mild to mild dementia (CDR 0.5-1).

Exclusion criteria

* Patients with moderate to severe dementia (CDR 2-3).

Design outcomes

Primary

MeasureTime frame
Change in rate of advance directive completion during or following the visitBaseline; Month 6; Month 12; Month 18
Change in the rate of completed advance directives that are uploaded to the patient's electronic medical recordBaseline; Month 6; Month 12; Month 18

Secondary

MeasureTime frameDescription
Change in Hospital Anxiety and Depression Scale (HADS)Baseline; Month 2; Month 3Scale consisting of 14 items (7 relating to anxiety; 7 to depression). Scores range from 0-21 (0-7 being normal; 08-10 being borderline abnormal; 11-21 being abnormal for anxiety and depression).
Change in Beck Hopelessness Scale (BHS)Baseline; Month 2; Month 3Scale consisting of 20 true-false items arrayed within three factors: Feelings about the future, loss of motivation, and future expectations. Scores range from 0-20 (0-3 as are considered within the normal range, 4-8 identify mild hopelessness, scores from 9-14 identify moderate hopelessness, and scores greater than 14 identify severe hopelessness).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026